CTRI Number |
CTRI/2025/06/089243 [Registered on: 20/06/2025] Trial Registered Prospectively |
Last Modified On: |
12/06/2025 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
How effective kulatthadi Kashay is will be checked in dysmenorrhea patients |
Scientific Title of Study
|
Randomized controlled clinical study to evaluate the efficacy of kulatthadi kashay in management of udavartini yonivyapad (primary dysmenorrhea) |
Trial Acronym |
Nil |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Sameeksha Chandrashekhar Charpe |
Designation |
PG Scholar |
Affiliation |
C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad India 431001 |
Address |
OPD No 19 Prasuti Tantra and Streeroga Department C.S.M.S.S
Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad
Maharashtra India 431011
Aurangabad
MAHARASHTRA
431011
India
Aurangabad MAHARASHTRA 431011 India |
Phone |
7709558572 |
Fax |
|
Email |
charpes98@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Sandhya M Yennawar |
Designation |
Associate Professor |
Affiliation |
C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad India 431001 |
Address |
OPD No 19 Prasuti Tantra and Streeroga Department C.S.M.S.S
Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad
Maharashtra India 431011
Aurangabad
MAHARASHTRA
431011
India
Aurangabad MAHARASHTRA 431011 India |
Phone |
9850562524 |
Fax |
|
Email |
dryennawar11@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Sameeksha Chandrashekhar Charpe |
Designation |
PG Scholar |
Affiliation |
C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad India 431001 |
Address |
OPD No 19 Prasuti Tantra and Streeroga Department C.S.M.S.S
Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad
Maharashtra India 431011
Aurangabad
MAHARASHTRA
431011
India
Aurangabad MAHARASHTRA 431011 India |
Phone |
7709558572 |
Fax |
|
Email |
charpes98@gmail.com |
|
Source of Monetary or Material Support
|
C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad India 431001 |
|
Primary Sponsor
|
Name |
C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad India 431001 |
Address |
C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad India 431001 |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Sameeksha Chandrashekhar Charpe |
C.S.M.S.S Ayurved Mahavidyalaya, Aurangabad |
OPD No 19 Prasuti Tantra and Streeroga Department C.S.M.S.S
Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad
Maharashtra India 431011
Aurangabad
MAHARASHTRA
431011
India Aurangabad MAHARASHTRA |
7709558572
charpes98@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
CSMSS Ayurved Mahavidyalaya Aurangabad |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: UDAVARTINI, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Comparator Arm | Drug | Other than Classical | | (1) Medicine Name: Shatapushpa Churna , Reference: NA, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 20 Days, anupAna/sahapAna: Yes(details: -Koshna Jal), Additional Information: -Duration of Treatment - 7 days prior and 3 days of menstruation in each cycle
Follow up -2 | 2 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Kulatthadi Kashay , Reference: Sahasrayog ( Shlok No-91), Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 25(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 20 Days, anupAna/sahapAna: No, Additional Information: -Duration of Treatment - 7 days prior and 3 days of menstruation in each cycle
Follow up - 2 |
|
|
Inclusion Criteria
|
Age From |
10.00 Year(s) |
Age To |
24.00 Year(s) |
Gender |
Female |
Details |
1. Diagnosed patients of Udavartini Yonivyapad of age group from 10 to 24 years young unmarried patient.
2. Patient having chief complaints of painful menstruation with associated symptoms without any pelvic pathology. |
|
ExclusionCriteria |
Details |
1. Patients of age group below 10 & above 24 years married patients.
2. Patients of pelvic pathology i.e. PID, PCOD, Cervical stenosis, Fibroid, Endometriosis, DUB, Adenomyosis, Endometrial polyp.
3. Patient taking any hormonal therapy.
4. Patient with congenital anomalies of reproductive system.
5. Menorrhagia |
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
Method of Concealment
|
Alternation |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Lakshanas of Udavartini Yonivyapad will decrease |
Baseline-30th, 60th day |
|
Secondary Outcome
|
Outcome |
TimePoints |
1.Study Udavartini yonivyapad according to
Ayurveda.
2.Study Primary Dysmenorrhea according to
Modern.
3.Compare the effect of Kulatthadi
Kashay and Shatapushpa churna in the
management of Udavartini Yonivyapad. |
Baseline-30th, 60th day |
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2/ Phase 3 |
Date of First Enrollment (India)
|
28/06/2025 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
In Ayurvedic classics Gynaecological disorders have been described under caption Yonivyapad. Among them Udavartini Yonivypad given by Acharya Charak is closely related to the symptoms of Primary Dysmenorrhea. Here Vata vitiated by vegadharana pushes the menstrual blood upward and then expel it out with difficulty leading to pain. Pain will relieve by itself once the menstrual flow starts, which itself indicate the spasmodic nature of pain. Acharya Sushrut said such symptoms in Udavarta Yonivyapad, the women eliminates frothy menstrual blood with difficulty. Acharya Vagbhat also mentioned Vata aggravated by suppression of the urges, torments the vagina and expels frothy menstrual blood with difficulty. All classical Samhitas like Charak Samhita, Sushrut Samhita, Vagbhat Samhita have mentioned Udavartini/Udavarta/ Udavritta Yonivyapad respectively as Vataj Yonivyapad. So Vatanulomak and Vatashamak dravyas have main role in treatment. Kulatthadi Kashay is one among lots of herbal preparation which has indication in Udavarta and shul. Prevalence of Dysmenorrhea in India is 70.2%. Majority of subjects experienced pain for 1-2 days during menstruation. 23.2% girls experienced pain for 2-3 days during menstruation. It is responsible for highest incidence of absenteeism resulting in loss of work hours and economic loss. Hence these females are forced to take antispasmodic, analgesics, prostaglandin synthetase inhibitors etc. during menstruation. However Prostaglandin synthetase inhibitors are contraindicated in women with gastrointestinal ulcer and bronchial asthma. Side effects includes nausea, vomiting, blurred vision, nephrotoxicity and gastric ulcer on prolong use. Previous studies on Udavartini Yonivyapad primarily focused on various types of Basti, and there are very few studies on oral medication. This reveals the necessity of alternate treatment to tackle this situation with suitable remedies. Kulatthadi Kashay mentioned in Sahasrayoga containing drugs which are Kulattha, Lahsun, Erand, Patha, Granthik, Nagar and Yavkshar having properties of Dipan, Pachan, Anuloman and Vedanashaman. Previously no research was done on Kulatthadi Kashay, considering above facts it is selected for study. Study will be conducted on 100 diagnosed patients of Udavartini Yonivyapad. Written consent will be taken. Initial assessment will be done. Patient treated with interventional group Kulatthadi Kashay and control group Shatapushpa Churna. Patients will be assessed at follow ups. Observation and Results will be noted and Statistical Analysis, Discussion and Conclusion will be drawn. |